{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:17:14Z","timestamp":1789154234194,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.diagmicrobio.2020.115149","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T19:47:21Z","timestamp":1595706441000},"page":"115149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predicting \u03b2-lactam resistance using whole genome sequencing in Klebsiella pneumoniae: the challenge of \u03b2-lactamase inhibitors"],"prefix":"10.1016","volume":"98","author":[{"given":"Andrea M.","family":"Hujer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Wesley","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena A.","family":"Taracila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Musser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0015","doi-asserted-by":"crossref","first-page":"e00528","DOI":"10.1128\/mBio.00528-17","article-title":"Klebsiella pneumoniae carbapenemase-2 (KPC-2), substitutions at Ambler position Asp179, and resistance to ceftazidime-avibactam: unique antibiotic-resistant phenotypes emerge from beta-lactamase protein engineering","volume":"8","author":"Barnes","year":"2017","journal-title":"mBio"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2020.115149_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1469-0691.2007.01849.x","article-title":"IRT and CMT beta-lactamases and inhibitor resistance","volume":"14","author":"Canton","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0025","series-title":"M100-S29. Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2019"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/civ837","article-title":"Rapid molecular diagnostics, antibiotic treatment decisions, and developing approaches to inform empiric therapy: PRIMERS I and II","volume":"62","author":"Evans","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/JCM.01524-16","article-title":"Informing antibiotic treatment decisions: evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against Acinetobacter spp. in PRIMERS III","volume":"55","author":"Evans","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0040","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/cid\/ciy801","article-title":"Rapid molecular diagnostics to inform empiric use of ceftazidime\/avibactam and ceftolozane\/tazobactam against Pseudomonas aeruginosa: PRIMERS IV","volume":"68","author":"Evans","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0045","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/jac\/dky082","article-title":"In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime\/avibactam treatment","volume":"73","author":"Gaibani","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0050","doi-asserted-by":"crossref","first-page":"763.e5","DOI":"10.1016\/j.cmi.2019.03.011","article-title":"Genomic characterization of a KPC-23\u2013producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam","volume":"25","author":"Galani","year":"2019","journal-title":"Clin Microbiol infect"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0055","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/jac\/dkz330","article-title":"Emergence of ceftazidime\/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo","volume":"74","author":"Gottig","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0060","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/AAC.48.7.2400-2408.2004","article-title":"Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae","volume":"48","author":"Haeggman","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0065","doi-asserted-by":"crossref","first-page":"e02534","DOI":"10.1128\/AAC.02534-16","article-title":"Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum beta-lactamases","volume":"61","author":"Haidar","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0070","doi-asserted-by":"crossref","first-page":"47719","DOI":"10.1074\/jbc.M207271200","article-title":"Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV beta-lactamase","volume":"277","author":"Helfand","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0075","doi-asserted-by":"crossref","first-page":"52724","DOI":"10.1074\/jbc.M306059200","article-title":"Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130","volume":"278","author":"Helfand","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-4838(01)00164-9","article-title":"Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance","volume":"1547","author":"Hujer","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0085","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.46.12.3971-3977.2002","article-title":"Amino acid substitutions at Ambler position Gly238 in the SHV-1 beta-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins","volume":"46","author":"Hujer","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007511","article-title":"VAMPr: VAriant Mapping and Prediction of antibiotic resistance via explainable features and machine learning","volume":"16","author":"Kim","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0095","doi-asserted-by":"crossref","first-page":"e00489","DOI":"10.1128\/mBio.00489-17","article-title":"Population genomic analysis of 1,777 extended-spectrum beta-lactamase\u2013producing Klebsiella pneumoniae isolates, Houston, Texas: unexpected abundance of clonal group 307","volume":"8","author":"Long","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0100","doi-asserted-by":"crossref","first-page":"e02243","DOI":"10.1128\/AAC.02243-16","article-title":"Can ceftazidime-avibactam and aztreonam overcome beta-lactam resistance conferred by metallo-beta-lactamases in Enterobacteriaceae?","volume":"61","author":"Marshall","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004949","article-title":"Natural variants of the KPC-2 carbapenemase have evolved increased catalytic efficiency for ceftazidime hydrolysis at the cost of enzyme stability","volume":"11","author":"Mehta","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0110","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1128\/AAC.00264-16","article-title":"Successful treatment of bloodstream infection due to metallo-beta-lactamase\u2013producing Stenotrophomonas maltophilia in a renal transplant patient","volume":"60","author":"Mojica","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0115","doi-asserted-by":"crossref","first-page":"e00486","DOI":"10.1128\/AAC.00486-17","article-title":"In vitro discordance with in vivo activity: humanized exposures of ceftazidime-avibactam, aztreonam, and tigecycline alone and in combination against New Delhi Metallo-beta-lactamase\u2013producing Klebsiella pneumoniae in a murine lung infection model","volume":"61","author":"Monogue","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41598-017-18972-w","article-title":"Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae","volume":"8","author":"Nguyen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jac\/dkz468","article-title":"In vitro selection of aztreonam\/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae","volume":"75","author":"Niu","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0130","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/jac\/dkz209","article-title":"Unravelling ceftazidime\/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity","volume":"74","author":"Oueslati","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmolb.2018.00016","article-title":"Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC beta-lactamases","volume":"5","author":"Palzkill","year":"2018","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.diagmicrobio.2015.02.003","article-title":"Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single beta-lactamases","volume":"82","author":"Papp-Wallace","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0145","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1099\/jmm.0.030577-0","article-title":"Role of SHV beta-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to beta-lactams in an Algerian hospital","volume":"60","author":"Ramdani-Bouguessa","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/cid\/cix417","article-title":"Whole-genome sequencing accurately identifies resistance to extended-spectrum beta-lactams for major gram-negative bacterial pathogens","volume":"65","author":"Shelburne","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0155","first-page":"2097","article-title":"Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx101","article-title":"Emergence of ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in Klebsiella pneumoniae Carbapenemase-producing K pneumoniae: a case report and review of literature","volume":"4","author":"Shields","year":"2017","journal-title":"Open forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0165","first-page":"35528","article-title":"Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase","volume":"280","author":"Sulton","year":"2005","journal-title":"Insights into the mechanism of inhibition J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0170","doi-asserted-by":"crossref","first-page":"e01923","DOI":"10.1128\/AAC.01923-18","article-title":"Applying rapid whole-genome sequencing to predict phenotypic antimicrobial susceptibility testing results among carbapenem-resistant Klebsiella pneumoniae clinical isolates","volume":"63","author":"Tamma","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115149_bb0175","series-title":"carrying both KPC-4 and NDM-1 carbapenemases","article-title":"Monitoring ceftazidime-avibactam (CAZ-AVI) and aztreonam (ATM) concentrations in the treatment of a bloodstream infection caused by a multidrug-resistant Enterobacter sp","author":"Yasmin","year":"2019"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320305265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320305265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:54:25Z","timestamp":1760003665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889320305265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0732889320305265"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115149","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting \u03b2-lactam resistance using whole genome sequencing in Klebsiella pneumoniae: the challenge of \u03b2-lactamase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115149"}}